Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Income from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

Evommune (EVMN) Interest Expenses (2024 - 2025)

Evommune (EVMN) has disclosed Interest Expenses for 2 consecutive years, with $9000.0 as the latest value for Q3 2025.

  • On a quarterly basis, Interest Expenses fell 47.06% to $9000.0 in Q3 2025 year-over-year; TTM through Dec 2025 was $26000.0, a N/A change, with the full-year FY2025 number at $50000.0, up 35.14% from a year prior.
  • Interest Expenses was $9000.0 for Q3 2025 at Evommune, down from $17000.0 in the prior quarter.
  • In the past five years, Interest Expenses ranged from a high of $17000.0 in Q3 2024 to a low of $9000.0 in Q3 2025.